Midkine inhibits apoptosis via extracellular signal regulated kinase (ERK) activation in PC12 cells

Journal of Medical and Dental Sciences

Volumn 46, Issue 1, 1999, Pages 45-51

  Owada, Kiyoshi ^a   Sanjyo, Nobuo ^a   Kobayashi, Takayoshi ^a   Kamata, Tomoyuki ^a   Mizusawa, Hidehiro ^a   Muramatsu, Hisako ^b   Muramatsu, Takashi ^b   Michikawa, Makoto ^c  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Apoptosis; ERK; MAPK; Midkine; PC12

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CARRIER PROTEIN; COLORING AGENT; CYTOKINE; ENZYME INHIBITOR; FLAVONOID; MIDKINE; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENT; RECOMBINANT PROTEIN; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL STRAIN; CULTURE MEDIUM; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; NICK END LABELING; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARRIER PROTEINS; COLORING AGENTS; CULTURE MEDIA, SERUM-FREE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; IN SITU NICK-END LABELING; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE GROWTH FACTORS; NEUROPROTECTIVE AGENTS; PC12 CELLS; RATS; RECOMBINANT PROTEINS; TETRAZOLIUM SALTS; THIAZOLES;

EID: 0033084966     PISSN: 13428810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kadomatsu K, Tomomura M, Muramatsu T. Midkine is a mediator of retinoic acid induced neuronal differentiation of embryonal carcinoma cells. Biochem Biophys Res Commun 1988; 151: 1312-1318.
2. Tomomura M, Kadomatsu K, Matsubara S, et al. A retinoic acid-responsive gene, MK, found in the teratocarcinoma system. Heterogeneity of the transcript and the nature of the translation product. J Biol Chem 1990; 265: 10765-10770.
3. Muramatsu H, Shirahama H, Yonezawa S, et al. Midkine, a retinoic acid inducible growth/differentiation factor: immunochemical evidence for the function and distribution. Dev Biol 1993; 159(2): 392-402.
4. Mitsiadis TA, Salmivirta M, Muramatsu T, et al. Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) are associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development 1995; 121: 37-51.
5. Nakanishi T, Kadomatsu K, Okamoto T, et al. Expression of syndecan-1 and -3 during embryogenesis of the central nervous system in relation to binding with midkine. J Biochem 1997; 121(2): 197-205.
6. Nakanishi T, Kadomatsu K, Okamoto T, et al. Expression of midkine and pleiotropin in ovarian tumors. Obstet Gynecol 1997; 90(2): 285-90.
7. Miyashiro I, Kaname T, Shin E, et al. Midkine expression in human breast cancers: expression of truncated form. Breast Cancer Res Treat 1997; 43(1): 1-6.
8. Adachi Y, Matsubara S, Pedraza C, et al. A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Research 1993; 53(6): 1281-5.
9. Mishima K, Asai A, Kadomatsu K, et al. Increased expression of midkine during the progression of human astrocytomas. 1997; Neurosci Lett 233(1): 29-32.
10. Michikawa M, Kikuchi S, Muramatsu H, et al. Retinoic acid responsive gene product, midkine, has neurotrophic functions for mouse spinal cord and dorsal root ganglion neurons in culture. J Neurosci Res 1993; 35(5): 530-539.
11. Kikuchi S, Muramatsu H, Muramatsu T, et al. Midkine a novel neurotrophic factor promotes survival of mesencephalic neurons in culture. Neurosci Lett 1993; 1260(1): 9-12.
12. Satoh J, Muramatsu H, Moretto G, et al. Midkine that promotes survival of fetal human neurons is produced by fetal human astrocytes in culture. Brain Res Dev Brain Res 1993; 75(2): 201-5.
13. Xia Z, Dickens M, Raingeaud J, et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270(24): 1326-1331.
14. Ratovitski EA, Burrow CR. Midkine stimulates Wilms' tumor cell proliferation via its signaling receptor. Cell Mol Biol 1997; 43(3): 425-31.
15. Dattani MT, Hindmarsh PC, Brook CG, et al. G120, a human growth hormone antagonist, shows Zinc-dependent agonist and antagonist activity on Nb2 cells. J Biol Chem 1995; 270: 9222-9226.
16. Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA. 1976; 73(7): 2424-2428.
17. Virdee K, Tolkovsky AM. Inhibition of p42 and p44 Mitogen-activated protein kinase activity by PD98059 does not suppress nerve growth factor-induced survival of sympathetic neurons. J Neurochem 1995; 67(5): 1801-1805.
18. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80: 179-185.
19. Rockow S, Tang J, Xiong W, et al. Nck inhibits NGF and basic FGF induced PC12 cell differentiation via mitogen-activated protein kinase-independent pathway. Oncogene 1996; 12: 2351-2359.
20. Cowley S, Paterson H, Kemp P, et al. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 1994; 77: 841-852.
21. Alblas J, Slager-Davidov R, Steenbergh PH, et al. The role of MAP kinase in TPA-mediated cell cycle arrest of human breast cancer cells. Oncogene 1998; 16: 131-139.
22. Dudley DT, Pang L, Decker SJ, et al. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 1995; 92: 7686-7689.
23. Ratovitski EA, Kotzbauer PT, Milbrandt J, et al. Midkine induces tumor cell proliferation and binds to a high affinity signaling receptor associated with JAK tyrosine kinases. J Biol Chem 1998; 273: 3654-3660.
24. Parrizas M, Saltiel AR, LeRoith D. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways. J Biol Chem 1997; 272: 154-161.